Independent and joint effects of antibodies to human heat-shock protein 60and Chlamydia pneumoniae infection in the development of coronary atherosclerosis

Citation
K. Burian et al., Independent and joint effects of antibodies to human heat-shock protein 60and Chlamydia pneumoniae infection in the development of coronary atherosclerosis, CIRCULATION, 103(11), 2001, pp. 1503-1508
Citations number
27
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
103
Issue
11
Year of publication
2001
Pages
1503 - 1508
Database
ISI
SICI code
0009-7322(20010320)103:11<1503:IAJEOA>2.0.ZU;2-J
Abstract
Background-Studies have suggested that the prevalence of antibodies against heat-shock proteins (HSPs), Chlamydia pneumoniae (Cpn), and cytomegaloviru s (CMV) is associated with coronary artery disease (CAD), but the independe nt or joint effects of human (h) HSP60 antibodies and these pathogens in pa tients have not been fully elucidated. Methods and Results-A total of 405 subjects (276 patients with CAD and 129 control individuals) were tested for serum antibodies to hHSP60, Cpn, and C MV immediate-early-1 (IE1) antigens. Patients were also assessed for serum cholesterol, triglyceride levels, and smoking habit. Significantly elevated levels of antibodies to hHSP60 and Cpn but not to CMV-IE1 antigens were do cumented in CAD patients, Multiple logistic regression analysis and subanal yses of selected subjects showed that these associations were independent o f age, sex, smoking, and serum lipid levels. Antibodies to hHSP60 and Cpn d id not correlate quantitatively; however, the relative risk of disease deve lopment was substantially increased in subjects with high antibody levels t o both hHSP60 and Cpn, reaching an odds ratio of 82.0 (95% CI 10.6 to 625.0 ), Conclusions-High levels of antibodies to hHSP60 and Cpn are independent ris k factors for coronary atherosclerosis, but their simultaneous presence sub stantially increases the risk for disease development,